Protocol No.: GS-US-334-1113

Title
A Long Term Follow-up Registry for Adolescent and Pediatric Subjects Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials.
Principal Investigator
Moffett, Kathryn S
Phase
NA
Age Group
Children
Applicable Disease Site
Infectious Diseases
Participating Institution
Health Sciences Center
Contact
Michelle Shaffer
Clinical Research Assoc
Phone: +1 304-293-2081

View on ClinicalTrials.gov